This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Wipro Cited A Leader In IDC MarketScape On Worldwide Life Science Research & Development – R&D ITO As Well As BPO Space

Stocks in this article: WIT

Wipro Ltd. (NYSE:WIT), a leading global information technology, consulting and outsourcing company, has been named a ‘Leader’ in both R&D ITO & BPO by advisory and research firm International Data Corporation (IDC) in its report IDC MarketScape: Worldwide Life Science Research & Development - BPO 2013 Vendor Assessment, Doc #244934, December 2013 and IDC MarketScape: Worldwide Life Science Research & Development – ITO 2013 Vendor Assessment, Doc #HI245309, December 2013.

After a close evaluation of Wipro's offerings and capabilities, IDC MarketScape has positioned Wipro in the ‘Leaders’ category within R&D ITO and R&D BPO. Relative to other vendors discussed in these reports, and based on feedback from multiple customer references, Wipro received high marks for its strong technical team, solid account relationships, and ability to deliver high value for the money.

Manoj Punja, Senior Vice President and Global Head, Wipro BPO, said, “The Life sciences industry is a huge focus area for Wipro BPO and we are investing significantly in this space. To be named as a Leader by IDC is indeed a validation of our investments and strategy in building differentiated industry capabilities, regulatory knowledge, analytics and best of class operations for this market.’’

Sangita Singh, Senior Vice President and Global Head - Healthcare and Life sciences, Wipro, said, “Wipro has reinforced its position in the R&D space. Wipro Healthcare and life sciences has been pursuing differentiated domain offerings to drive sustainable and predictable growth. We have gained traction, by following Wipro’s three-pronged strategy of programmatic mining of existing accounts, new logo pursuits and creating differentiated domain offerings to solve real problems faced by clients.”

Within the Life Science R&D BPO space, Wipro has been quoted as a strong player particularly in the area of delivering enterprise content document management, drug safety services, post market surveillance, and training services. In the Life Science R&D ITO space, Wipro is particularly strong in delivering both industry-specific and industry-agnostic engineering and software ITO services, supplemented by a broad portfolio of traditional life science ITO offerings.

1 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 18,053.71 +23.50 0.13%
S&P 500 2,088.77 +6.89 0.33%
NASDAQ 4,806.8590 +33.3870 0.70%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs